Received Nov 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
shingles immediately afterwards; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles (Verbatim: shingles immediately afterwards). The outcome of the shingles was resolved. It was unknown if the reporter considered the shingles to be related to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 18-NOV-2025 This case was reported by a consumer via interactive digital media. The reporter reported that his/her in-laws got the shot, and both ended up with shingles immediately afterwards. Father-in-law lasted a couple of weeks. The batch number was not provided and unable to contact the reporter. This case is linked with US2025AMR150029, reported by same reporter.; Sender's Comments: US-GSK-US2025AMR150029:Same reporter different patient